Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

D-SOLVE Cohorts (Cohort a and B)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Hepatitis D is by far the most severe form of chronic viral hepatitis, frequently leading to liver failure, hepatocellular carcinoma and death. Hepatitis D is caused by coinfection Hepatitis D is caused by co-infection with hepatitis B virus (HBV) and hepatitis D virus (HDV). This multicenter cohort should enable a comprehensive and unbiased biomarker screening of well-defined HDV-infected patients, followed by mechanistic studies to determine the functional role of distinct molecules. Patient surveillance strategies and antiviral treatment approaches could be personalized which should reduce clinical and social disease burden, improve quality of life and save direct and indirect costs caused by HDV infection.

Who May Be Eligible (Plain English)

Who May Qualify: - Anti-HDV positive - ≥18 years old - Sex: m/f/d - willing to sign a consent form for prospective procedures Who Should NOT Join This Trial: - Anti-HDV negative Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Anti-HDV positive * ≥18 years old * Sex: m/f/d * Informed consent for prospective procedures Exclusion Criteria: * Anti-HDV negative

Locations (4)

Hannover Medical School, Department of Gastroenterology, Hepatology, Infectious Disease and Endocrinology
Hanover, Germany
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (University of Milan)
Milan, Italy
Institutul de Boli Infectioase "Prof. Dr. Matei Bals"
Bucharest, Romania
Karolinska University Hospital and Karolinska Institutet
Stockholm, Sweden